Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01068847 · ClinicalTrials.gov registry record · Phase 1
Drug Discrimination in Methadone-Maintained Humans Study 3
A Phase 1 study of Drug Dependence, sponsored by University of Arkansas.
- Completed
- Registry status
- Phase 1
- Development phase
- 9
- Enrollment target
- 1
- Study location
NCT01068847 is a Phase 1 study of Drug Dependence that has completed, run by University of Arkansas. The registered enrollment target is 9 participants, below the 304-participant average among 9 other Drug Dependence trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01068847, a Phase 1 study of Drug Dependence, has completed, sponsored by University of Arkansas.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 9 participants
- Enrollment target
- 1
- Study location
Study Summary
This study involves giving psychoactive drugs intramuscularly (injected into the muscle of the upper arm or the hip) and/or orally, and measuring the participant's ability to tell the difference between one drug and another, as well as measuring the effects of the drugs on mood, physiology (e.g., heart rate, blood pressure, respiration rate) and behavior. Each participant will receive 2-4 of the listed interventions.
Conditions Studied
Interventions
- DRUG 2-4 of the drugs listed below
Study Locations (1)
Arkansas
- University of Arkansas for Medical Sciences - Little Rock
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2010-02 |
| Est. Completion | 2012-11 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01068847
The ClinicalTrials.gov registry entry for NCT01068847 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 9 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 304-participant average among 9 other Drug Dependence trials with a reported enrollment target (97% lower). The listed sponsor is University of Arkansas, which has 318 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Drug Dependence appearing as the primary indexed condition, and to 1 intervention - of which 2-4 of the drugs listed below is the first listed.
NCT01068847 reports 1 study location spanning 1 distinct geographic area - top geographies include Arkansas.
Frequently Asked Questions
What is clinical trial NCT01068847 about?
NCT01068847 is a clinical study titled "Drug Discrimination in Methadone-Maintained Humans Study 3". This study involves giving psychoactive drugs intramuscularly (injected into the muscle of the upper arm or the hip) and/or orally, and measuring the participant's ability to tell the difference between one drug and another, as well as measuring the effects of the drugs on mood, physiology (e.g., he...
What is the current status of trial NCT01068847?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 9 participants. The study started on 2010-02. Estimated completion is 2012-11.
What conditions does trial NCT01068847 study?
This clinical trial studies the following conditions: Drug Dependence.
What interventions are being tested in trial NCT01068847?
The interventions under investigation include: 2-4 of the drugs listed below (DRUG).
Who is sponsoring clinical trial NCT01068847?
This trial is sponsored by University of Arkansas, which has 318 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01068847 being conducted?
This trial has 1 study location across Arkansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Drug Dependence
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
CB1R in Synthetic Psychoactive Cannabinoids
ACTIVE NOT RECRUITING · NA
-
Assessing Screening Plus Brief Intervention's Resulting Efficacy (ASPIRE) to Stop Drug Use
COMPLETED · Phase 3
-
Integrated Treatment of OEF/OIF Veterans With PTSD & Substance Use Disorders
COMPLETED · NA
-
The Effect of Fetal Gender on Maternal Substance Abuse Treatment
COMPLETED
-
Making Alcoholics Anonymous Easier
COMPLETED · Phase 3
-
Intensive Outpatient Versus Outpatient Treatment With Buprenorphine Among African Americans
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.